Active telomere elongation by a subclass of cancer-associated POT1 mutations
Genes & Development · 2025
DOI: 10.1101/gad.352492.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, 2025. Verfasst von Annika Martin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, USA. Hauptthemen laut MEDLINE: Telomere-Binding Proteins, Mutation, Neoplasms, Telomere. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, American Cancer Society.
Abstract (Originalsprache)
Mutations in the shelterin protein POT1 are associated with diverse cancers and thought to drive carcinogenesis by impairing POT1's suppression of aberrant telomere elongation. To classify clinical variants of uncertain significance (VUSs) and identify cancer-driving loss-of-function mutations, we developed a locally haploid human stem cell system to evaluate >1900 POT1 mutations, including >600 VUSs. Unexpectedly, many validated familial cancer-associated POT1 (caPOT1) mutations are haplosufficient for cellular viability, indicating that some pathogenic alleles do not act through a loss-of-function mechanism. Instead, POT1's DNA damage response suppression and telomere length control are genetically separable. ATR inhibition enables isolation of frameshift mutants, demonstrating that the only essential function of POT1 is to repress ATR. Furthermore, comparison of caPOT1 and frameshift alleles reveals a class of caPOT1 mutations that elongate telomeres more rapidly than full loss-of-function alleles. This telomere length-promoting activity is independent from POT1's role in overhang sequestration and fill-in synthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, USA.
- MRC Laboratory of Molecular Biology; Cambridge CB2 0QH, United Kingdom.
- Computer Science Division, University of California, Berkeley, Berkeley, California 94720, USA.
- Department of Statistics, University of California, Berkeley, Berkeley, California 94720, USA.
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, USA; hockemeyer@berkeley.edu hanqinli@berkeley.edu.
- Innovative Genomics Institute, University of California, Berkeley, Berkeley, California 94720, USA.
ORCID-Profile: John Boyle, Yun S Song
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- American Cancer Society
- Siebel Stem Cell Institute
- National Institutes of Health
- California Institute for Regenerative Medicine
- Jane Coffin Childs
- CRISPR Cures for Cancer Initiative
Zitieren
APA
Martin, A., Schabort, J., Bartke-Croughan, R., Tran, S., Preetham, A., Lu, R., Ho, R., Gao, J., Jenkins, S., Boyle, J., Ghanim, G. E., Jagota, M., Song, Y. S., Li, H., & Hockemeyer, D. (2025). Active telomere elongation by a subclass of cancer-associated POT1 mutations. Genes & Development. https://doi.org/10.1101/gad.352492.124
Vancouver
Martin A, Schabort J, Bartke-Croughan R, Tran S, Preetham A, Lu R, et al. Active telomere elongation by a subclass of cancer-associated POT1 mutations. Genes & Development. 2025. doi:10.1101/gad.352492.124
BibTeX
@article{Martin2025,
author = {Martin, Annika and Schabort, Johannes and Bartke-Croughan, Rebecca and Tran, Stella and Preetham, Atul and Lu, Robert and Ho, Richard and Gao, Jianpu and Jenkins, Shirin and Boyle, John and Ghanim, George E and Jagota, Milind and Song, Yun S and Li, Hanqin and Hockemeyer, Dirk},
title = {Active telomere elongation by a subclass of cancer-associated POT1 mutations},
journal = {Genes & Development},
year = {2025},
doi = {10.1101/gad.352492.124}
}
EUVIMED